Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
As part of the European Medicines Agency’s (EMA) EU-Competitiveness initiative, representatives from the agency visited Leiden Bio Science Park for an in-depth conversation with the local life sciences ecosystem. The goal: to raise awareness of regulatory support tools, including the Innovation Task Force, Scientific Advice, and PRIME, that can help innovators bring therapies to patients faster and more effectively.
The visit brought together investors, academic leaders, incubator experts, and business development professionals, highlighting how Leiden Bio Science Park actively bridges the worlds of science, entrepreneurship, and patient access. Discussions focused on aligning regulatory support with early-stage development and strengthening Europe’s competitiveness through strategic collaboration.
We were honoured to host Emmanuel Cormier, Head of Regulatory Science and Innovation at EMA, and Sebastian Asprella, Programme Lead for EU Competitiveness, and deeply appreciate their openness to dialogue.
Key voices from our ecosystem included:
Rob Mayfield (LEH) on early-stage investment
Stefan Ellenbroek (unlock_) on start-up growth and valorisation
Prof. Hubertus Irth on the academic perspective
Prof. Pieter H. Reitsma, Elmer Maurits, and Marieke van der Lans on biotech development and scale-up journeys
The visit was facilitated by the Leiden Bio Science Park team, with Esther Peters, Amoy Anderson, and Victor van der Horst coordinating conversations across stakeholders.
This meeting was a clear signal that regulatory science, entrepreneurial readiness, and investment strategy are converging and that innovation clusters like Leiden play a vital role in shaping Europe’s life sciences future.
A new research collaboration between TNO, Logick Energetics B.V., and InnoSer has officially kicked off at Leiden Bio Science Park, supported by a TKI-LSH grant. The partners...
The Faculty of Science at Leiden University is offering a new opportunity for professionals to deepen their knowledge of data-driven decision-making, complex systems, and...
𝗪𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝘄𝗵𝗲𝗻 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝟭𝟱 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗽𝗲𝗻 𝘁𝗵𝗲𝗶𝗿 𝗱𝗼𝗼𝗿𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗽𝘂𝗯𝗹𝗶𝗰? You get an Open Day that brings together over 2,400 visitors, families, students,...